MedTrace Logo

MRI-Guided Cryoablation for Focal Native Prostate Cancer

NCT04797039 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-05-07

No results posted yet for this study

Summary

The purpose of this research is to collect data about the MRI cryoablation procedure your doctor(s) would normally perform in order to treat the participants focal prostate cancer and to evaluate the participants condition after the participants treatment is performed.

Participants have been asked to take part in this research because the participants have been diagnosed with prostate cancer and scheduled to have an ablation procedure.

Conditions

  • Primary Malignant Neoplasm of Prostate (Diagnosis)

Interventions

PROCEDURE

MR guided cryoablation

MR guided cryoablation of focal biopsy proven prostate cancer

Sponsors & Collaborators

Eligibility

Min Age
30 Years
Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04797039 on ClinicalTrials.gov